Sugi Predict

Sugi Predict / Compounds / SCHEMBL22024550

SCHEMBL22024550

SCHEMBL22024550

Cc1ccc(C(=O)Nc2cc(CN3CCN(C)CC3)cc(C(F)(F)F)c2)cc1Nc1cc(-c2cccnc2)nc2[nH]ccc12

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIKFYVE Q9Y2I7 2/20 0.65
▸ ABL1 P00519 11/20 0.56
▸ DDR2 Q16832 6/20 0.55
▸ DDR1 Q08345 5/20 0.55
▸ KIT P10721 5/20 0.55
▸ CSF1R P07333 4/20 0.55
▸ BCR P11274 7/20 0.55
▸ LYN P07948 4/20 0.55
▸ BRAF P15056 5/20 0.54
▸ PDGFRA P16234 3/20 0.54
▸ EGFR P00533 3/20 0.54
▸ ERBB2 P04626 2/20 0.54
▸ LCK P06239 2/20 0.54
▸ FYN P06241 2/20 0.54
▸ PDGFRB P09619 2/20 0.54
▸ FGR P09769 2/20 0.54
▸ SRC P12931 2/20 0.54
▸ NQO2 P16083 2/20 0.54
▸ EPHA8 P29322 2/20 0.54
▸ ABL2 P42684 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22024548 0.93 DDR2 (0.56) PIKFYVEABL1DDR2DDR1KIT
SCHEMBL22024549 0.91 PIKFYVE (0.59) PIKFYVEABL1DDR2DDR1KIT
SCHEMBL22024553 0.88 PIKFYVE (0.80) PIKFYVEABL1DDR2DDR1KIT
SCHEMBL22025015 0.87 ABL1 (0.74) PIKFYVEABL1KITCSF1RBCR
SCHEMBL22024868 0.85 PIKFYVE (0.64) PIKFYVEABL1KITCSF1RBCR
SCHEMBL22024709 0.84 DDR2 (0.52) PIKFYVEABL1DDR2DDR1KIT
SCHEMBL22024551 0.83 PIKFYVE (0.88) PIKFYVEABL1DDR2DDR1KIT
SCHEMBL13219960 0.83 DDR2 (0.72) ABL1DDR2DDR1KITCSF1R
SCHEMBL22065350 0.81 DDR2 (0.57) ABL1DDR2DDR1KITCSF1R
SCHEMBL22024633 0.81 PIKFYVE (0.67) PIKFYVEABL1DDR2DDR1KIT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11352354-B2 Substituted penta-fused hexa-heterocyclic compounds, preparation method therefor, drug combination and use thereof XIAMEN UNIVERSITY (CN) 2022-06-07 — — US disclosed
EP-3663293-A1 SUBSTITUTED PENTA- AND HEXA-HETEROCYCLIC COMPOUNDS, PREPARATION METHOD THEREFOR, DRUG COMBINATION AND USE THEREOF Xiamen University (CN) 2020-06-10 — — EP disclosed
US-20200165246-A1 SUBSTITUTED PENTA-FUSED HEXA-HETEROCYCLIC COMPOUNDS, PREPARATION METHOD THEREFOR, DRUG COMBINATION AND USE THEREOF XIAMEN UNIVERSITY (CN) 2020-05-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11352354-B2 Substituted penta-fused hexa-heterocyclic compounds, preparation method therefor, drug combination and use thereof PIKFYVE, PIK3CA, PIK3C2A PIKFYVE 1/4885ABL1 1429/4885DDR2 2054/4885
US-20200165246-A1 SUBSTITUTED PENTA-FUSED HEXA-HETEROCYCLIC COMPOUNDS, PREPARATION METHOD THEREFOR, DRUG COMBINATION AND USE THEREOF PIKFYVE, PIK3CA, PIK3C2A PIKFYVE 1/4885ABL1 1429/4885DDR2 2054/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback